Biomarker Receptor Occupancy
Biomarker Receptor Occupancy - Related Videos
01:21
Measuring Cerebral Blood Volume in the Auditory Cortex Using Vascular Space Occupancy
0 Views •
2025
Position a human participant’s head within the head coil of a functional magnetic resonance imaging, or fMRI, system.Employ vascular space occupancy or VASO, a technique to measure changes in cerebral blood volume, or CBV, the blood volume within the brain.Begin by applying an inversion recovery pulse to suppress signals from blood, allowing only signals from the surrounding tissue within the region to be detected.Next, use MRI-compatible earbuds to deliver auditory stimuli.The stimuli reach...
12:02
Collection and Extraction of Occupational Air Samples for Analysis of Fungal DNA
0 Views •
Cited by 2 •
2018
Determining the fungal diversity within an environment is a method utilized in occupational health studies to identify health hazards. This protocol describes DNA extraction from occupational air samples for amplification and sequencing of fungal ITS regions. This approach detects many fungal species that can be overlooked by traditional assessment methods.
08:29
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
0 Views •
Cited by 29 •
2012
We describe a rat model of post traumatic stress disorder (PTSD) that reveals the persistent alterations in neuroendocrine function and the delayed long-term, exaggerated fear response, characteristic of PTSD patients. The animal model and methods described here are useful for correlating biomarkers in brain nuclei, which are mechanistic but cannot be measured in patients, with biomarkers in peripheral white blood cells, which can.
10:22
Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
0 Views •
2015
Human microRNAs translocate from host erythrocytes to Plasmodium falciparum parasites. Here, the techniques used to transfect synthetic microRNAs into host erythrocytes and isolate all RNAs from P. falciparum are described. In addition, this paper will detail a method of polysome isolation in P. falciparum to determine the ribosomal occupancy and translational potential of parasite transcripts.
08:28
An Overview of bGDGT Biomarker Analysis for Paleoclimatology
0 Views •
2023
Source: Laboratory of Jeff Salacup - University of Massachusetts Amherst Throughout this series of videos, natural samples were extracted and purified in search of organic compounds, called biomarkers, that can relate information on climates and environments of the past. One of the samples analyzed was sediment. Sediments accumulate over geologic time in basins, depressions in the Earth into which sediment flows through the action of fluid (water or air), movement, and gravity. Two main types...
FAQs
Occupancy generally reflects how much drug reaches the target, how strongly it binds, and whether other ligands compete for the same receptor. Increasing dose or exposure can increase receptor binding, while affinity determines how effectively the compound occupies the target. These variables help explain differences between administered dose and the receptor-level engagement measured in a biological system.
A labeled tracer, binding assay, or imaging probe provides a way to distinguish receptors that remain available from receptors occupied by the test compound. That distinction converts drug binding into a measurable biomarker rather than relying only on drug concentration. The selected measurement approach can therefore connect target-site activity with findings from cells, tissues, or the central nervous system.
Receptor occupancy can serve as an intermediate link between pharmacokinetics, which describes drug exposure, and pharmacodynamic effects, which describe biological responses. Comparing exposure with measured target engagement helps show whether a compound reaches and interacts with its intended receptor. This relationship can clarify dose-response patterns and support interpretation of efficacy or safety findings.
The measurement indicates whether a therapy is interacting with its intended receptor at the biological site of action. When interpreted with exposure and pharmacodynamic results, it can help distinguish insufficient target engagement from other reasons for limited treatment response. This makes the biomarker useful for evaluating whether observed clinical or experimental effects are consistent with receptor-level activity.
Studies may use a labeled tracer, a binding assay, or an imaging probe to assess receptor availability and drug-related binding. The practical choice depends on whether the target is examined in blood cells, tissues, or the central nervous system. Each approach supplies evidence about receptor engagement, which can then be related to exposure and pharmacodynamic outcomes.
Clinical researchers can use these biomarkers when they need evidence that a proposed dose engages the intended receptor before interpreting efficacy or safety results. Occupancy measurements help relate administered dose and drug exposure to target binding, providing a biological basis for comparing dose levels. This supports selection of doses that produce measurable receptor engagement in the studied system.
Receptor occupancy data can be compared with treatment response, efficacy findings, and safety observations to assess how receptor engagement relates to clinical outcomes. High or low occupancy may help place those outcomes in the context of target activity and exposure. The approach is especially relevant when therapies act on receptors located in blood cells, tissues, or the central nervous system.